Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenofibrate with UDCA in Primary Biliary Cirrhosis
NCT01141296Phase 2Withdrawn
- Sponsor
- University of Miami
- Start
- Apr 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary biliary cholangitis (PBC) comparing Fenofibrate with Placebo (2 arms). Primary endpoint: Serum alkaline phosphatase level at 1 year. Planned start Apr 2011; status: withdrawn.
02
Drugs
fenofibrate
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT01141296.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01141296.